Clinical Trial Update: Study to Assess dHER2+AS15 Cancer Vaccine Given in Combination With Lapatinib to Patients With Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating dHER2+ AS15 cancer vaccine in combination with lapatinib for metastatic breast cancer has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Lapatinib (Lapatinib)
• dHER2+ AS15 cancer vaccine (dHER2+ AS15 cancer vaccine)

Snippet

Sponsor: Michael Morse, MD | Conditions: Metastatic Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-12-20